Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFkappaB suppression (Q34498207)

2 August 2017

1 reference

title

Mechanisms of immune evasion by renal cell carcinoma: tumor-induced T-lymphocyte apoptosis and NFkappaB suppression (English)

1 reference

evasion of host immune response

2 August 2017

1 reference

1 reference

Christopher S Ng

1

1 reference

2 August 2017

Andrew C Novick

2

1 reference

2 August 2017

Charles S Tannenbaum

3

1 reference

2 August 2017

Ronald M Bukowski

4

1 reference

2 August 2017

James H Finke

5

1 reference

2 August 2017

language of work or name

English

0 references

publication date

1 January 2002

1 reference

2 August 2017

1 reference

2 August 2017

59

1 reference

2 August 2017

1

1 reference

2 August 2017

9-14

1 reference

The role of medroxyprogesterone acetate (MPA) in the treatment of renal adenocarcinoma

2 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Natural history and therapy of metastatic renal cell carcinoma: the role of interleukin-2.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Tumor-infiltrating lymphocytes in patients with renal-cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

A new gene coding for an antigen recognized by autologous cytolytic T lymphocytes on a human renal carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

T-cell adoptive immunotherapy of metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Dendritic cell-based immunotherapy of renal cell carcinoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Regression of human metastatic renal cell carcinoma after vaccination with tumor cell-dendritic cell hybrids

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Regression of Metastatic Renal-Cell Carcinoma after Nonmyeloablative Allogeneic Peripheral-Blood Stem-Cell Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Defective granzyme B gene expression and lytic response in T lymphocytes infiltrating human renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Inducibility of kappa immunoglobulin enhancer-binding protein Nf-kappa B by a posttranslational mechanism

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

The NF-kappa B and I kappa B proteins: new discoveries and insights

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Rel/NF-kappa B transcription factors and the control of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

I kappa B proteins: structure, function and regulation

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

A cytokine-responsive IkappaB kinase that activates the transcription factor NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Alterations in NFkappaB activation in T lymphocytes of patients with renal cell carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Renal cell carcinoma-derived gangliosides suppress nuclear factor-kappaB activation in T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Immunosuppression by human gangliosides: I. Relationship of carbohydrate structure to the inhibition of T cell responses

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Immunosuppression by human gangliosides. II. Carbohydrate structure and inhibition of human NK activity

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Functional Role of Glycosphingolipids in Tumor Progression

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Aberrant expression of gangliosides in human renal cell carcinomas.

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Changes in glycolipids in human renal-cell carcinoma and their clinical significance

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

Apoptotic pathways: the roads to ruin

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

IAP family proteins--suppressors of apoptosis

1 reference

https://api.crossref.org/works/10.1016%2FS0090-4295%2801%2901503-5

7 January 2021

10.1016/S0090-4295(01)01503-5

Identifiers

DOI

1 reference

2 August 2017

1 reference